Literature DB >> 21206989

[Clinical algorithm of cutaneous extragenital wart treatment].

A Rübben1.   

Abstract

Various human papillomavirus of the genera α-, β-, γ-, μ- and η-papillomavirus induce type-specific extragenital warts. Plantar, common and plane warts are the most common types. The closely related Alpha-papillomaviruses HPV 2, 27 and 57 are responsible for the majority of therapy-resistant common warts. A wide armamentarium of surgical, physical, chemical or drug therapies is available but no modality cures all patients. In order to avoid overtreatment it is mandatory to differentiate between indolent warts which will spontaneously resolve, warts which cause acute discomfort and warts without any tendency to heal spontaneously. HPV type, wart type, localization, size, disease duration as well as age and immune status are parameters influencing self-healing and should be considered when choosing the appropriate wart therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21206989     DOI: 10.1007/s00105-010-2027-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  37 in total

1.  Selective CD4+ T cell lymphocytopenia and recalcitrant warts in an 8-year-old child.

Authors:  J A Van Wagoner; D A Khan
Journal:  Ann Allergy Asthma Immunol       Date:  2001-11       Impact factor: 6.347

2.  Guidelines for the management of cutaneous warts.

Authors:  J C Sterling; S Handfield-Jones; P M Hudson
Journal:  Br J Dermatol       Date:  2001-01       Impact factor: 9.302

3.  Clinical features and age distribution of patients with HPV 2/27/57-induced common warts.

Authors:  A Rübben; K Kalka; B Spelten; E I Grussendorf-Conen
Journal:  Arch Dermatol Res       Date:  1997-05       Impact factor: 3.017

4.  Common warts from immunocompetent patients show the same distribution of human papillomavirus types as common warts from immunocompromised patients.

Authors:  A Rübben; R Krones; B Schwetschenau; E I Grussendorf-Conen
Journal:  Br J Dermatol       Date:  1993-03       Impact factor: 9.302

Review 5.  Cutaneous warts: an evidence-based approach to therapy.

Authors:  Rocky Bacelieri; Sandra Marchese Johnson
Journal:  Am Fam Physician       Date:  2005-08-15       Impact factor: 3.292

6.  Skin cancer and warts in immunosuppressed renal transplant recipients.

Authors:  I M Leigh; M T Glover
Journal:  Recent Results Cancer Res       Date:  1995

7.  An assessment of methods of treating viral warts by comparative treatment trials based on a standard design.

Authors:  M H Bunney; M W Nolan; D A Williams
Journal:  Br J Dermatol       Date:  1976-06       Impact factor: 9.302

8.  Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.

Authors:  Tim Waterboer; Rachel Neale; Kristina M Michael; Peter Sehr; Maurits N C de Koning; Sönke J Weißenborn; Francesca Sampogna; Damiano Abeni; Adele C Green; Jan Nico Bouwes Bavinck; Michael Pawlita
Journal:  J Gen Virol       Date:  2009-04-22       Impact factor: 3.891

9.  Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities.

Authors:  E-I Grussendorf-Conen; S Jacobs; A Rübben; U Dethlefsen
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

10.  The descriptive epidemiology of warts in British schoolchildren.

Authors:  H C Williams; A Pottier; D Strachan
Journal:  Br J Dermatol       Date:  1993-05       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.